The Steven J. Parker Memorial Developmental-Behavioral Pediatric Conference: Clinical Problems in Primary Care

March 28-29, 2014
Royal Sonesta Hotel, Cambridge, MA
View the Printed Brochure!

BPEDS14_banner

Accreditation | Agenda | Faculty | Accommodations | Registration | Syllabus

 

Learn more about the Boston Medical Center’s Division of Developmental and Behavioral Pediatrics:
http://www.bu.edu/today/2014/a-helping-hand-for-children-with-disabilities-at-bmc/

 

Target Audience

Primary care physicians, pediatricians, pediatric nurse practitioners, nurses, child mental health professionals and family nurse practitioners, social workers

 

Educational Needs Addressed

Emotional and behavioral problems among children and adolescents continue to be highly prevalent and their significance for well-being is well documented but the vast majority of children…are still unidentified and untreated (Academic Pediatrics, Volume 10, Number 4, July – August 2010 252-259).

Early identification of developmental disorders is critical to the well-being of children and their families. It is an integral function of the primary care medical home and an appropriate responsibility of all pediatric health care professionals. Delayed or disordered development can be caused by specific medical conditions and may indicate an increased risk of other medical complications. Delayed or disordered development may also indicate an increased risk of behavior disorders or associated developmental disorders. Early identification should lead to further evaluation, diagnosis, and treatment. Early intervention is available for a wide range of developmental disorders; their prompt identification can spur specific and appropriate therapeutic interventions. Identification of a developmental disorder and its underlying etiology may also affect a range of treatment planning, from medical treatment of the child to family planning for his or her parents. In order to identify a delay, pediatric clinicians need to be aware of what problems exist and how they manifest.

Of nearly 7.4 million children in the United States diagnosed with emotional, behavioral, or developmental conditions, a disproportionate number do not get the mental health services they need because they are under insured, according to a new report released by the Health Resources and Services Administration (HRSA). The study also finds that boys, adolescents, and children from low-income families are affected by conditions such as depression or Attention Deficit Disorder at higher rates than other children, but that adequate health services for these children remain an unmet need.

The report, “The Mental and Emotional Well-Being of Children: A Portrait of States and the Nation 2007,” identified seven emotional, behavioral, or developmental conditions: depression, anxiety, Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder, conduct disorders, autism spectrum disorders, developmental delay and Tourette Syndrome. Children with these conditions can benefit from a variety of therapies including counseling and medication.

This conference will address many of these gaps.

In addition, in this conference we will focus on two theme specific modules. The first will be a session around issues of development in the developing world and in the U.S.:  different world or same issues? The second in collaboration with the Department of Child Psychiatry at Boston Medical Center, will focus on the changes in diagnostics with the new DSM-V.

 

Educational Objectives

Through lectures and question and answer sessions, participants at the conclusion of this conference will be able to:

  • Describe the latest clinical information on developmental and behavioral issues in children and families
  • Identify such problems in their practice and work settings
  • Choose and provide appropriate treatment for such issues

 

Accreditation

Physician Accreditation
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 13.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This continuing medical education activity has been reviewed by the American Academy of Pediatrics and is acceptable for a maximum of 13.00 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.

This live activity, The Steven J. Parker Memorial Development-Behavioral Pediatric Conference: Clinical Problems in Primary Care, with a beginning date of March 28, 2014, has been reviewed and is acceptable for up to 13 Elective credits by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Accreditation
Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Contact Hours: 13.25 (1.5 Pharmacotherapeutic Credit)

This program has been approved by the National Association of Pediatric Nurse Practitioners, Inc., (NAPNAP) Continuing Education Committee for the following contact hours: 13 contact hours of which 1.5 contact hours are pharmacology. (Program #A10-14-04)

Social Work Accreditation
This program has been approved for 13.0 Social Work Continuing Education Credits, for the licensure period of October 1, 2012 — September 30, 2014, in accordance with 258 CMR.  Boston University School of Social Work Authorization Number B-14-448

 

Disclosure Policy

It is the policy of Boston University School of Medicine Department of Continuing Medical Education, that faculty disclose to program participants any real or apparent conflict of interest. In addition, the faculty is asked to disclose any discussion pertaining to the unapproved use of pharmaceuticals and devices. Complete disclosure information will be available on site in the printed course materials.